Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease. - Wikidata - wikimedia - TriplyDB

Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease.

Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease.

http://www.wikidata.org/entity/Q34016698

about

Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies Modulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas disease Benznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatments Evaluation of Parasiticide Treatment with Benznidazol in the Electrocardiographic, Clinical, and Serological Evolution of Chagas Disease Is Chagas disease really the "new HIV/AIDS of the Americas"?Serological and parasitological response in chronic Chagas patients 3 years after nifurtimox treatment Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review.Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia.Perturbed T cell IL-7 receptor signaling in chronic Chagas disease.Characterization of an immunodominant antigenic epitope from Trypanosoma cruzi as a biomarker of chronic Chagas' disease pathology.Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives.Highly discordant serology against Trypanosoma cruzi in central Veracruz, Mexico: role of the antigen used for diagnostic.Emerging and under-recognized Chagas cardiomyopathy in non-endemic countries Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study.Serological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern Argentina Effects of a novel β-lapachone derivative on Trypanosoma cruzi: Parasite death involving apoptosis, autophagy and necrosis.Towards a paradigm shift in the treatment of chronic Chagas disease.A serological, parasitological and clinical evaluation of untreated Chagas disease patients and those treated with benznidazole before and thirteen years after intervention.Diagnosis and management of Chagas disease and cardiomyopathy.Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review.Recent clinical trials for the etiological treatment of chronic chagas disease: advances, challenges and perspectives.Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses Success of benznidazole chemotherapy in chronic Trypanosoma cruzi-infected patients with a sustained negative PCR result.Chagas disease in non-endemic countries: epidemiology, clinical presentation and treatment.Bimodal distribution of Trypanosoma cruzi antibody levels in blood donors from a highly endemic area of Argentina: what is the significance of low-reactive samples?The Significance of Discordant Serology in Chagas Disease: Enhanced T-Cell Immunity to Trypanosoma cruzi in Serodiscordant Subjects.Recent Developments in Sterol 14-demethylase Inhibitors for Chagas Disease.A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients.Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure.Distinct Treatment Outcomes of Antiparasitic Therapy in -Infected Children Is Associated With Early Changes in Cytokines, Chemokines, and T-Cell Phenotypes

P2860

Q26782118-568546C0-B3A5-4254-B963-7386E89A41BF Q28083346-33A6C57B-D2CA-48CC-9C06-97A3F3A76687 Q28535357-20B1418A-BE76-484C-977A-8B3BA9265863 Q28550722-EC166224-1623-456B-BBC6-169E8D2A2B22 Q34474584-E3ED16A2-0D54-456A-AE34-5DEF4BE19731 Q34584940-07A98EB7-CF88-4114-8233-83E0F52D2A50 Q34992879-61A5474C-03D0-46E0-A580-74D90DA2B898 Q35130398-86D86411-5294-4703-AA98-1C26B994891B Q35348204-D54F1B7E-410B-4367-964E-C9ADE3C10051 Q35739066-A8E9078B-75A4-49AD-BA79-38AE2BD4EA72 Q35810790-17ADB126-4C39-48C2-9C94-CAA610800C50 Q36069974-DB11C8EB-48C7-454D-9AA6-240BA6C6CB2B Q36170517-4661722C-1765-421B-A8CB-BDA8BD9FAF2A Q36526649-41A65B42-37D9-4748-84DC-D610751410CD Q37007518-B6A51446-769D-4C71-98EF-3E8072CFA9B9 Q37363592-A2161364-8243-4994-81A7-7FCC2656C67A Q37544885-B0E69AFF-4712-4170-BCDF-34A5D2D9C057 Q37675152-F7732802-2DE4-439D-AAC7-7A5CFED6335D Q38030830-CEBC98A9-AFD9-403F-A8F1-FCCC42C619A1 Q38195336-A212EBAC-D76B-42D2-9EE6-E99B9793DA33 Q38256874-5CFA9E4C-5A6F-4E09-8874-202F6CE69892 Q38871286-FBDA8884-EB43-4E1C-9F45-F547FF6CEE56 Q39282269-081CFF74-BC39-4400-B21F-5EE04824D305 Q39372756-481312BD-462D-4474-BEA5-B4F46AA71F4B Q39392248-EDD78DA5-2E16-421E-AEAC-A465C19649E3 Q41665227-AD0A1749-319C-46F4-A98C-ACDC484C85B6 Q41955446-7F4391A6-1598-4B54-9810-84D5976E08C5 Q50099507-3A9426DE-3C1A-41E9-90BE-E9748AD1F211 Q54248570-B9E67B2D-98A6-41A1-907D-25CF3B4183A3 Q57110653-2A71CF02-2E75-4CFF-8611-E55E02E37D74

P2860

Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease.

http://www.wikidata.org/entity/Q34016698

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Impact of aetiological treatme ...... ogy in chronic Chagas disease.

@ast

Impact of aetiological treatme ...... ogy in chronic Chagas disease.

@en

Impact of aetiological treatme ...... ogy in chronic Chagas disease.

@nl

type

label

Impact of aetiological treatme ...... ogy in chronic Chagas disease.

@ast

Impact of aetiological treatme ...... ogy in chronic Chagas disease.

@en

Impact of aetiological treatme ...... ogy in chronic Chagas disease.

@nl

prefLabel

Impact of aetiological treatme ...... ogy in chronic Chagas disease.

@ast

Impact of aetiological treatme ...... ogy in chronic Chagas disease.

@en

Impact of aetiological treatme ...... ogy in chronic Chagas disease.

@nl

P1433

Q34016698-8719D442-F747-46DE-945D-91C4ECF2FC5D

P1476

Q34016698-AECAAD06-C13C-4DC2-AB02-8C1B2D80D2BA

P2093

Q34016698-03D2CB31-2BE7-453F-A38D-E8134BA48471

Q34016698-14833E74-42D1-4E21-BF9F-99AB61C04867

Q34016698-6A600288-656E-4206-A9DB-9239C9938DE1

Q34016698-6D38BBC6-C1E8-41EF-8299-0755EF2748FA

Q34016698-96DC3B36-D849-4F80-8F33-C380F12CBEA9

Q34016698-9C466CBC-1344-48C6-85B6-FED57A170C1E

Q34016698-A5107607-5950-4CC3-BEC9-AE923C8C7EFD

Q34016698-CE8D2DDE-2D26-4445-BA25-AD06F6E0B0C9

Q34016698-D0899E7F-632E-483D-8040-8EF45A6963E2

Q34016698-E9ECC1AA-40CB-433E-B55F-F3FA536C8363

P2860

Q34016698-03DA26D4-CB33-4A4E-B33E-5BE40D43617B

Q34016698-0981B1CF-CE7D-481B-AC0B-9984CC30AAC1

Q34016698-135D85A5-FEA5-41E5-B679-77B145A2F023

Q34016698-1A091C5F-B112-4973-8BB6-2EF8943C2C38

Q34016698-1E916408-EFD8-4ADA-AA8B-D8AE2677A72E

Q34016698-217FCBD2-F43A-4571-9130-755F3634082D

Q34016698-25C49D4C-A533-4DD9-A224-E07F7D7D3B33

Q34016698-295BB85C-4583-4FEE-B390-9F0E81ABEB52

Q34016698-3D17F80E-EB75-454D-813D-3EBAB7764375

Q34016698-422EA93B-C2FD-4E83-B33B-06B3A1964A8D

P304

Q34016698-7FBE0516-89F1-4299-9AAE-5B9C32BD0B35

P31

Q34016698-2AE73CD8-F893-4368-B8B5-FBABC17A53F0

P356

Q34016698-28B57E4C-835F-402D-912A-C55A6EBB610E

P407

Q34016698-645A0445-CC7F-4C61-BD3B-DB6C38D9026A

P433

Q34016698-9515A8F0-CFA8-4F3E-9651-53B749DAC0A3

P478

Q34016698-D503BB25-5D73-4F26-A03A-56CDF8C7F3CE

P50

Q34016698-7F71C8C0-F917-4962-BF1B-62305860926F

P577

Q34016698-B9534E41-DFBC-4F97-B3B1-9543DF7104B3

P5875

Q34016698-1A6A4990-C869-4F57-9B40-6F7A614A0E9F

P698

Q34016698-DBD8240C-06B0-4EDB-A816-3A4563DB1948

P921

Q34016698-E5A037EE-D1BE-4015-BC38-723BA5C7FB3C

P932

Q34016698-20EF7DDA-2BAE-47C2-AB0F-646D210D6137

P356

JOURNAL.PNTD.0001314

P1433

PLOS Neglected Tropical Diseases

P1476

Impact of aetiological treatme ...... ogy in chronic Chagas disease.

@en

P2093

Alejandro Armenti

http://www.w3.org/2001/XMLSchema#string

Ana María De Rissio

http://www.w3.org/2001/XMLSchema#string

Bruno Lococo

http://www.w3.org/2001/XMLSchema#string

Carlos Vigliano

http://www.w3.org/2001/XMLSchema#string

Graciela Bertocchi

http://www.w3.org/2001/XMLSchema#string

Gretchen Cooley

http://www.w3.org/2001/XMLSchema#string

Marcos Petti

http://www.w3.org/2001/XMLSchema#string

María Gabriela Alvarez

http://www.w3.org/2001/XMLSchema#string

Rodolfo Viotti

http://www.w3.org/2001/XMLSchema#string

Susana Laucella

http://www.w3.org/2001/XMLSchema#string

P2860

High throughput selection of effective serodiagnostics for Trypanosoma cruzi infection

IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis

Changes in Trypanosoma cruzi-specific immune responses after treatment: surrogate markers of treatment efficacy.

Progressive chronic Chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives.

Parasite persistence in the aetiology of Chagas disease.

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

Evaluation and treatment of chagas disease in the United States: a systematic review.

Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease.

Pathophysiology of the heart in Chagas' disease: current status and new developments.

Serological evaluation of specific-antibody levels in patients treated for chronic Chagas' disease

P304

e1314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PNTD.0001314

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Rick L. Tarleton

P577

2011-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51640858

http://www.w3.org/2001/XMLSchema#string

P698

21909451

http://www.w3.org/2001/XMLSchema#string

P921

P932

3167788

http://www.w3.org/2001/XMLSchema#string